Patent Security Agreement
Exhibit 10.6
Patent Security Agreement, dated as of January 29, 2015 by Marathon Patent Group, Inc. and the undersigned entities (collectively, the “Pledgor”), in favor of DBD Credit Funding LLC, in its capacity as collateral agent pursuant to the Revenue Sharing and Securities Purchase Agreement (in such capacity, the “Collateral Agent”).
W i t n e s s e t h:
Whereas, the Pledgor is party to a Security Agreement of even date herewith (the “Security Agreement”) in favor of the Collateral Agent pursuant to which the Pledgor is required to execute and deliver this Patent Security Agreement;
Now, Therefore, in consideration of the premises and to induce the Collateral Agent, for the benefit of the Secured Parties, to enter into the Revenue Sharing and Securities Purchase Agreement, the Pledgor hereby agrees with the Collateral Agent as follows:
SECTION 1. Defined Terms. Unless otherwise defined herein, terms defined in the Security Agreement and used herein have the meaning given to them in the Security Agreement.
SECTION 2. Grant of Security Interest in Patent Collateral. The Pledgor hereby pledges and grants to the Collateral Agent for the benefit of the Secured Parties a lien on and security interest in and to all of its right, title and interest in, to and under all the following Collateral:
(a) all of the Company’s existing and future acquired Patents, including, but not limited to, the items listed on Schedule A attached hereto; and
(b) all Proceeds of any and all of the foregoing.
SECTION 3. Security Agreement. The security interests granted to the Collateral Agent pursuant to this Patent Security Agreement are granted in conjunction with the security interests granted to the Collateral Agent pursuant to the Security Agreement, and Pledgor hereby acknowledges and affirms that the rights and remedies of the Collateral Agent with respect to the security interests in the Patents made and granted hereby are set forth in the Security Agreement, the terms and provisions of which are incorporated by reference herein as if fully set forth herein. In the event that any provision of this Patent Security Agreement is deemed to conflict with the Security Agreement, the provisions of the Security Agreement shall control.
SECTION 4. Counterparts. This Patent Security Agreement may be executed in any number of counterparts, all of which shall constitute one and the same instrument, and any party hereto may execute this Patent Security Agreement by signing and delivering one or more counterparts. Delivery of an executed counterpart of a signature page of this Patent Security Agreement by telecopier or other electronic transmission (i.e. a “pdf” or “tif” document) shall be effective as delivery of a manually executed counterpart of this Patent Security Agreement.
[Signature page follows]
In Witness Whereof, the Pledgor has caused this Patent Security Agreement to be executed and delivered by its duly authorized offer as of the date first set forth above.
Very truly yours,
Pledgor:
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
SAMPO IP, LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
RELAY IP, INC.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
CYBERFONE SYSTEMS, LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
VANTAGE POINT TECHNOLOGY, INC.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
CRFD RESEARCH, INC.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
E2E PROCESSING, INC.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
LOOPBACK TECHNOLOGIES, INC.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
LOOPBACK TECHNOLOGIES II, INC.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
SIGNAL IP, INC.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
HYBRID SEQUENCE IP, INC.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
PME ACQUISITION LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
SOEMS ACQUISITION CORP.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
IP LIQUIDITY VENTURES ACQUISITION LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
IP LIQUIDITY VENTURES, LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
SARIF BIOMEDICAL ACQUISITION LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
SARIF BIOMEDICAL LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
SELENE COMMUNICATION TECHNOLOGIES ACQUISITION LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
SELENE COMMUNICATION TECHNOLOGIES, LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
DA ACQUISITION LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
DYNAMIC ADVANCES, LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
CLOUDING CORP.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
TLI ACQUISITION CORP.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
TLI COMMUNICATIONS LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
MEDTECH GROUP ACQUISITION CORP.
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: CEO
TLIF, LLC
/s/ Xxxx Xxxxxxx
__________________________________________
By: Xxxx Xxxxxxx
Title: Manager
Accepted and Agreed:
DBD Credit Funding LLC
as Collateral Agent
By: /s/ Xxxxxxxxxxx X. Xxxxxxxx
Name: Xxxxxxxxxxx X. Xxxxxxxx
Title: President
SCHEDULE A
PATENTS
The confidential portion has been so omitted and filed separately with the Securities and Exchange Commission (“SEC”).
